A Study of Intrathecal Hydromorphone for Pediatric Idiopathic Scoliosis Repair

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Pain Control
Interventions
DRUG

Hydromorphone 2.5 mcg/kg

2.5 mcg/kg intrathecal

DRUG

Hydromorphone 2.75 mcg/kg

2.75 mcg/kg intrathecal

DRUG

Hydromorphone 3 mcg/kg

3 mcg/kg intrathecal

DRUG

Hydromorphone 3.25 mcg/kg

3.25 mcg/kg intrathecal

DRUG

Hydromorphone 3.5 mcg/kg

3.5 mcg/kg intrathecal

DRUG

Hydromorphone 4 mcg/kg

4 mcg/kg intrathecal

DRUG

Hydromorphone 4.5 mcg/kg

4.5 mcg/kg intrathecal

DRUG

Hydromorphone 5 mcg/kg

5 mcg/kg intrathecal

Trial Locations (1)

55905

RECRUITING

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05552443 - A Study of Intrathecal Hydromorphone for Pediatric Idiopathic Scoliosis Repair | Biotech Hunter | Biotech Hunter